HIV protease inhibitors: a review of molecular selectivity and toxicity
Zhengtong Lv,* Yuan Chu,* Yong Wang Department of Immunology, School of Basic Medical Science, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China *Both authors contributed equally to this work Abstract: Highly active antiretroviral therapy (...
Guardado en:
Autores principales: | Lv Z, Chu Y, Wang Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5948916cbb8a4cfcb98afcb99d70ab6b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani I, et al.
Publicado: (2013) -
Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
por: Kann G, et al.
Publicado: (2021) -
Pediatric palliative care for youth with HIV/AIDS: systematic review of the literature
por: Wilkins ML, et al.
Publicado: (2013) -
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review
por: Wilton J, et al.
Publicado: (2015) -
A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV
por: Kebodeaux CD, et al.
Publicado: (2013)